Global Ophthalmic Market: Focus on Glaucoma

Glaucoma is a type of disease that causes an irreversible blindness, if it is left undetected or untreated. Moreover there is no cure for glaucoma and regular medication is the only way to prevent blindness. In fact this is one of the main issues in the treatment of glaucoma, regularity in taking a proper medication course. Most people are not able to take the complete medication and the rate of medication regimen non-compliance is very high.

Nearly half of the people who are being prescribed for medication discontinue only after six months due to various reasons. Another inherent characteristic of glaucoma and a deterrent in proper treatment is that most of the times this disease goes unnoticed.

The market for ophthalmology and glaucoma consists of prescription or treatment and surgical or detection devices. The prescription or pharmaceuticals market is comparatively larger than the devices market both for ophthalmic and glaucoma. Contact Lenses is another significant market for ophthalmology. Region-wise US is the largest market for ophthalmic and glaucoma alike, and the global market is about 2-3 times that of the US market. Alcon, Allergan, Merck and Pfizer are main players.
[Studien Infos ausblenden]

1. Glaucoma: An Introduction

Types of Glaucoma
Open-Angle Glaucoma
Angle-Closure Glaucoma
Glaucoma Tests
Glaucoma Treatment
Laser Treatment
Surgical Treatment

2. Ophthalmic Market Size

2.1 Global Ophthalmic Market

Market by Region
Market Segments

2.2 US Ophthalmic Market

Market Segments

2.3 Japanese Ophthalmic Market

Growth Rate

3. Glaucoma Market Size

3.1 Global Glaucoma Market

Market Value
Market Share

3.2 US Glaucoma Market

Market Value
Market Share

4. Market Dynamics

4.1 Market Trends

Growing Aging Population
Irregularity in Adhering to Drug Treatment
Unawareness about Suffering from Glaucoma

4.2 New Product Developments

Punctal Plug Drug Delivery System
NicOx/Pfizer’s Glaucoma Drug
Alcon’s TRAVATANZ[TM] Approval in Japan
Lexicon Pharmaceuticals Identifies New Drug Candidate
Othera Pharmaceuticals Files Investigational New Drug

5. Company Profiles

5.1 Alcon

Overview
Business Strategies
Reaching Out to Customers Globally
Research Commitment to Ophthalmology

5.2 Allergan

Overview
Business Strategies
Improving Operating Efficiency
Diversity of Product Lines

5.3 Pfizer

Overview
Business Strategies
Acquisitions, Licensing and Collaborations
Cost Reduction Strategy

5.4 Merck & Co.

Overview
Business Strategies
Focus on Customer Needs
Business Efficiency

6. Market Forecast

Ophthalmic Market Forecast
Glaucoma Market Forecast
[Inhaltsverzeichnis ausblenden]

Ophthalmic Market Segments
Region-wise CAGR of Global Prescription Ophthalmic Market (2005-10E)
Growth of Japanese Prescription Ophthalmic Market by Segments (2005-10E)

Types of Glaucoma
Glaucoma Tests
Global Prescription Ophthalmic Market by Region (2000/05/10E)
Segment-wise Division of Regional Ophthalmic Market
Global Ophthalmic Market by Segments (2006-07)
US Ophthalmic Market by Segments (2004-2007)
Japanese Prescription Ophthalmic Market by Segments (2005/10E)
Global Glaucoma Market Size and Growth (2006-2008E)
Market Share of Leading Market Players (2007)
Glaucoma Market Share by Drug Types (2007)
US Glaucoma Market Value (2006-08)
Market Share of US Glaucoma Market (2007)
Sales Growth of Alcon (2003-07)
Sales Growth of Allergan (2003-07)
Sales Growth of Pfizer (2003-07)
Sales Growth of Merck (2003-07)
Global Ophthalmic Market Forecast (2008E-10E)
US Ophthalmic Market Forecast (2008-11E)
Global Glaucoma Market Forecast (2009-12E)
US Glaucoma Market Forecast (2009-12E)
[Tabellenverzeichnis ausblenden]